Thermo Fisher Scientific Inc. (BVMF:TMOS34)

Market Cap	1.06T -18.2%
Revenue (ttm)	245.41B +3.9%
Net Income	36.93B +5.8%
EPS	97.71 +7.3%
Shares Out	n/a
PE Ratio	28.83
Forward PE	22.22
Dividend	0.13 (0.23%)
Ex-Dividend Date	Dec 12, 2025

Volume	7,022
Average Volume	4,434
Open	59.33
Previous Close	59.83
Day's Range	58.36 - 59.33
52-Week Range	44.33 - 71.97
Beta	0.95
RSI	26.63
Earnings Date	Jan 29, 2026

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of drugs and vaccines, as well as diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for phar...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1956
• Employees: 125,000
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: TMOS34

Financial Performance

In 2025, Thermo Fisher Scientific's revenue was $44.56 billion, an increase of 3.91% compared to the previous year's $42.88 billion. Earnings were $6.70 billion, an increase of 5.82%.

Financial numbers in USD